FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1979127621> ?p ?o ?g. }

• W1979127621 endingPage "83" @default.
• W1979127621 startingPage "83" @default.
• W1979127621 abstract "Antiplatelet therapy is the cornerstone of treatment for patients with acute coronary syndrome undergoing percutaneous coronary intervention. Clopidogrel, in combination with aspirin, is associated with improvement in longterm vascular clinical outcomes in these patients and is currently the antiplatelet standard of care. However, a significant number of patients still experience secondary ischemic thrombotic events due to potential insufficient platelet inhibition or noncompliance. Therefore, the development of better and safer antiplatelet agents is of the utmost priority. Indeed, oral antiplatelet agents, such as aspirin in the ISIS-2 study and clopidogrel in the COMMIT mega trial, in moderate doses are among the very few classes of drugs that reduce absolute mortality in patients after acute vascular thrombotic events. Prasugrel (CS-747; LY-640315), an experimental third-generation oral thienopyridine, is a specific, irreversible antagonist of the platelet adenosine diphosphate P2Y(12) receptor. Preclinical and early phase clinical studies have shown that prasugrel has greater antiplatelet potency, lower variability in platelet response and faster onset of inhibition than clopidogrel. However, the doses of the drug chosen for further prasugrel developments are much higher (about 2.5-2.7 times higher) than those of conventional clopidogrel regimen(s). The recent TRITON trial assessed head-to-head prasugrel versus clopidogrel, both in addition to aspirin, and led to numerous controversies with regard to the fairness of the trial design, interpretation of its results, and the suitability of the high maintenance prasugrel dose for chronic preventive human use. We critically review various aspects of prasugrel development, focusing on the discrepancies between the official interpretation of the results and actual findings. We conclude that the benefits of prasugrel are exaggerated and that the risks are underestimated. Very careful maintenance dose selection and a flawless long-term safety profile for the new agents will become the keys to the success of future oral antiplatelet drug development." @default.
• W1979127621 created "2016-06-24" @default.
• W1979127621 creator A5004123286 @default.
• W1979127621 creator A5004325105 @default.
• W1979127621 creator A5017654932 @default.
• W1979127621 creator A5019693310 @default.
• W1979127621 creator A5021365551 @default.
• W1979127621 creator A5026239581 @default.
• W1979127621 creator A5029728911 @default.
• W1979127621 creator A5041441691 @default.
• W1979127621 creator A5066471533 @default.
• W1979127621 creator A5075574806 @default.
• W1979127621 creator A5075755767 @default.
• W1979127621 date "2009-01-01" @default.
• W1979127621 modified "2023-10-09" @default.
• W1979127621 title "Prasugrel for arterial coronary thrombosis" @default.
• W1979127621 cites W1553345686 @default.
• W1979127621 cites W1895723152 @default.
• W1979127621 cites W1936929261 @default.
• W1979127621 cites W1964687996 @default.
• W1979127621 cites W1969408372 @default.
• W1979127621 cites W1976115338 @default.
• W1979127621 cites W1985511956 @default.
• W1979127621 cites W1985835171 @default.
• W1979127621 cites W1986315531 @default.
• W1979127621 cites W1994364461 @default.
• W1979127621 cites W1999587028 @default.
• W1979127621 cites W2002572303 @default.
• W1979127621 cites W2003593234 @default.
• W1979127621 cites W2004239884 @default.
• W1979127621 cites W2019840235 @default.
• W1979127621 cites W2020353475 @default.
• W1979127621 cites W2023097406 @default.
• W1979127621 cites W2030886847 @default.
• W1979127621 cites W2031797534 @default.
• W1979127621 cites W2033441782 @default.
• W1979127621 cites W2033682440 @default.
• W1979127621 cites W2037029114 @default.
• W1979127621 cites W2040659551 @default.
• W1979127621 cites W2042437855 @default.
• W1979127621 cites W2045715230 @default.
• W1979127621 cites W2047366876 @default.
• W1979127621 cites W2048280539 @default.
• W1979127621 cites W2054332590 @default.
• W1979127621 cites W2054654286 @default.
• W1979127621 cites W2057681387 @default.
• W1979127621 cites W2059875511 @default.
• W1979127621 cites W2068976846 @default.
• W1979127621 cites W2069981713 @default.
• W1979127621 cites W2070419967 @default.
• W1979127621 cites W2082902898 @default.
• W1979127621 cites W2083038715 @default.
• W1979127621 cites W2083878136 @default.
• W1979127621 cites W2088308053 @default.
• W1979127621 cites W2095927374 @default.
• W1979127621 cites W2097572841 @default.
• W1979127621 cites W2103847217 @default.
• W1979127621 cites W2106272472 @default.
• W1979127621 cites W2110108344 @default.
• W1979127621 cites W2110755408 @default.
• W1979127621 cites W2111633730 @default.
• W1979127621 cites W2113395588 @default.
• W1979127621 cites W2114280314 @default.
• W1979127621 cites W2115166163 @default.
• W1979127621 cites W2116457054 @default.
• W1979127621 cites W2117047223 @default.
• W1979127621 cites W2125915009 @default.
• W1979127621 cites W2133972984 @default.
• W1979127621 cites W2140220482 @default.
• W1979127621 cites W2142403455 @default.
• W1979127621 cites W2147235559 @default.
• W1979127621 cites W2152823642 @default.
• W1979127621 cites W2152890478 @default.
• W1979127621 cites W2154134447 @default.
• W1979127621 cites W2155224405 @default.
• W1979127621 cites W2156506897 @default.
• W1979127621 cites W2159465232 @default.
• W1979127621 cites W2160088199 @default.
• W1979127621 cites W2162238964 @default.
• W1979127621 cites W2163273882 @default.
• W1979127621 cites W2164578451 @default.
• W1979127621 cites W2165782674 @default.
• W1979127621 cites W2168795101 @default.
• W1979127621 cites W2171013482 @default.
• W1979127621 cites W2288646582 @default.
• W1979127621 cites W2401825435 @default.
• W1979127621 cites W2412075846 @default.
• W1979127621 cites W2470272844 @default.
• W1979127621 cites W2527032421 @default.
• W1979127621 cites W2598074109 @default.
• W1979127621 cites W42396170 @default.
• W1979127621 cites W906589 @default.
• W1979127621 doi "https://doi.org/10.1358/dot.2009.45.2.1322478" @default.
• W1979127621 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/20011699" @default.
• W1979127621 hasPublicationYear "2009" @default.
• W1979127621 type Work @default.
• W1979127621 sameAs 1979127621 @default.
• W1979127621 citedByCount "16" @default.

• next